Balance Sheet Components (Tables)

3 Months Ended

Mar. 31, 2026

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets as of March 31, 2026 and December 31, 2025 consist of the following (in thousands):


		March 31, 2026				December 31, 2025
Prepaid manufacturing and research expenses		$	5,832			$	1,908
Prepaid insurance			158				262
Prepaid professional fees			—				223
GST receivable			655				817
Other			242				422
Total prepaid expenses and other current assets		$	6,887			$	3,632

Schedule of Property and Equipment, Net

Property and equipment, net as of March 31, 2026 and December 31, 2025 consist of the following (in thousands):


		March 31, 2026				December 31, 2025
Equipment		$	223			$	223
Furniture and fixtures			18				18
Property and equipment, at cost			241				241
Less accumulated depreciation			(131	)			(112	)
Total property and equipment, net		$	110			$	129

Schedule of Other Assets

Other assets as of March 31, 2026 and December 31, 2025 consist of the following (in thousands):


		March 31, 2026				December 31, 2025
Clinical trial deposits		$	1,846			$	2,036
Other			157				25
Total other assets		$	2,003			$	2,061

Components of Accrued Liabilities

Accrued liabilities as of March 31, 2026 and December 31, 2025 consist of the following (in thousands):


		March 31, 2026				December 31, 2025
Accrued legal and professional fees		$	91			$	163
Accrued compensation			878				2,250
Accrued manufacturing and research expenses			8,545				7,374
Accrued issuance costs			40				40
Deferred R&D credit			927				927
Accrued other expenses			82				8
Total accrued liabilities		$	10,563			$	10,762